Oral Nirmatrelvirâ€“Ritonavir as Postexposure Prophylaxis for Covid-19
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Safety and Efficacy of Concomitant Nirmatrelvir/Ritonavir and Direct Oral Anticoagulant Therapies for COVID-19 Among Patients With Atrial Fibrillation.
